Corporate Governance25 Sept 2026, 12:04 pm
Mangalam Drugs Closes Trading Window for Q2 FY27 Results
AI Summary
Mangalam Drugs & Organics Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended September 30, 2026. This measure is standard practice to prevent insider trading during the sensitive period of financial result announcement.
Key Highlights
- Trading window closed for designated persons and immediate relatives.
- Closure effective from October 1, 2026.
- Window reopens 48 hours after Q2 FY27 unaudited results declaration.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
- Standard procedure to prevent insider trading.
Price Impact
More from MANGALAM